British drugmaker AstraZeneca on Thursday said annual earnings were set to rise more than expected after a strong third quarter.
Net profit more than tripled to $770 million (710 million euros) in the three months to the end of September compared with one year earlier, AstraZeneca said in a statement.
"Our financial performance in the year to date... underpinned today's upgrade to full-year guidance," said chief executive Pascal Soriot.
"2016 will be a pivotal year in our strategic journey as we face the impact of loss of exclusivity to (anti-cholesterol drug) Crestor in the US."
AstraZeneca said it now expects "a mid to high single-digit percent increase" in annual core earnings per share compared with "a low single-digit percent increase".
Name (required) *
E-mail (required, but will not be published) *
Notify me of follow-up comments
Ben Stokes gave England a firm grip on the first Test with bat and ball before Shakib Al Hasan's 5-79 revived Bangladesh…
The facade of the world's tallest building, the Burj Khalifa in the Gulf emirate of Dubai, was lit up in pink Thursday…
The London Fashion Week (LFW) is one of the most sought out shows of the year. LFW is an annual fashion event…
Powered and Developed by FilmMatters
Copyright © 2016 Arabtoday